UBS AM
HOLX

UBS AM’s Hologic HOLX Stock Holding History

UBS AM’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,299,022
Closed -$174M – 3794
2026
Q1 		$174M Buy
2,299,022
+236,716
+11% +$17.8M 0.04% 398
2025
Q4 		$154M Sell
2,062,306
-49,038
-2% -$3.58M 0.03% 415
2025
Q3 		$142M Sell
2,111,344
-483,339
-19% -$32.1M 0.03% 414
2025
Q2 		$169M Buy
2,594,683
+349,339
+16% +$20.9M 0.03% 421
2025
Q1 		$139M Sell
2,245,344
-38,887
-2% -$2.58M 0.04% 452
2024
Q4 		$165M Buy
2,284,231
+312,614
+16% +$24.4M 0.04% 403
2024
Q3 		$161M Buy
1,971,617
+16,057
+0.8% +$1.28M 0.04% 397
2024
Q2 		$145M Buy
1,955,560
+369,126
+23% +$27.7M 0.04% 371
2024
Q1 		$124M Sell
1,586,434
-43,712
-3% -$3.25M 0.04% 390
2023
Q4 		$116M Sell
1,630,146
-66,023
-4% -$4.6M 0.05% 395
2023
Q3 		$118M Sell
1,696,169
-56,471
-3% -$4.27M 0.05% 367
2023
Q2 		$141M Hold
1,752,640
– – 0.07% 312
2023
Q1 		$141M Buy
1,752,640
+55,274
+3% +$4.45M 0.07% 312
2022
Q4 		$127M Buy
1,697,366
+19,561
+1% +$1.39M 0.07% 330
2022
Q3 		$108M Sell
1,677,805
-57,312
-3% -$3.97M 0.06% 350
2022
Q2 		$120M Sell
1,735,117
-203,423
-10% -$15.1M 0.06% 333
2022
Q1 		$149M Buy
1,938,540
+171,445
+10% +$12.3M 0.06% 318
2021
Q4 		$135M Sell
1,767,095
-152,291
-8% -$11.2M 0.05% 370
2021
Q3 		$142M Sell
1,919,386
-369,187
-16% -$27.7M 0.06% 332
2021
Q2 		$153M Buy
2,288,573
+555,193
+32% +$37.1M 0.07% 322
2021
Q1 		$129M Sell
1,733,380
-589,843
-25% -$44.8M 0.06% 351
2020
Q4 		$169M Buy
2,323,223
+594,505
+34% +$42M 0.08% 256
2020
Q3 		$115M Buy
1,728,718
+382,831
+28% +$24.2M 0.06% 305
2020
Q2 		$76.7M Buy
1,345,887
+138,578
+11% +$6.8M 0.05% 376
2020
Q1 		$42.4M Buy
1,207,309
+102,898
+9% +$4.9M 0.03% 494
2019
Q4 		$57.7M Buy
1,104,411
+12,135
+1% +$604K 0.04% 488
2019
Q3 		$55.1M Buy
1,092,276
+66,165
+6% +$3.26M 0.04% 481
2019
Q2 		$49.3M Buy
1,026,111
+33,560
+3% +$1.55M 0.04% 523
2019
Q1 		$48M Buy
992,551
+12,099
+1% +$546K 0.04% 499
2018
Q4 		$40.3M Buy
980,452
+24,855
+3% +$1.02M 0.03% 515
2018
Q3 		$39.2M Sell
955,597
-23,273
-2% -$941K 0.03% 572
2018
Q2 		$38.9M Buy
978,870
+68,651
+8% +$2.64M 0.03% 583
2018
Q1 		$34M Buy
910,219
+165,178
+22% +$6.67M 0.03% 625
2017
Q4 		$31.9M Sell
745,041
-48,366
-6% -$1.93M 0.03% 610
2017
Q3 		$29.1M Sell
793,407
-149,199
-16% -$6.02M 0.03% 623
2017
Q2 		$42.8M Buy
942,606
+74,457
+9% +$3.29M 0.04% 467
2017
Q1 		$36.9M Sell
868,149
-578,296
-40% -$23.6M 0.04% 496
2016
Q4 		$58M Buy
1,446,445
+798,541
+123% +$30.8M 0.07% 327
2016
Q3 		$25.2M Sell
647,904
-3,138
-0.5% -$118K 0.03% 595
2016
Q2 		$22.5M Buy
651,042
+13,229
+2% +$458K 0.03% 629
2016
Q1 		$22M Buy
637,813
+7,810
+1% +$272K 0.03% 631
2015
Q4 		$24.4M Sell
630,003
-27,743
-4% -$1.08M 0.03% 593
2015
Q3 		$25.7M Buy
657,746
+33,939
+5% +$1.35M 0.03% 587
2015
Q2 		$23.7M Buy
623,807
+44,955
+8% +$1.57M 0.02% 659
2015
Q1 		$19.1M Sell
578,852
-53,220
-8% -$1.63M 0.02% 718
2014
Q4 		$16.9M Buy
632,072
+37,980
+6% +$980K 0.02% 738
2014
Q3 		$14.5M Sell
594,092
-16,092
-3% -$406K 0.01% 754
2014
Q2 		$15.5M Buy
610,184
+17,206
+3% +$402K 0.02% 741
2014
Q1 		$12.7M Buy
592,978
+33,353
+6% +$720K 0.01% 784
2013
Q4 		$12.5M Sell
559,625
-5,502
-1% -$121K 0.01% 767
2013
Q3 		$11.7M Sell
565,127
-11,927
-2% -$254K 0.01% 763
2013
Q2 		$11.1M Buy
+577,054
New +$12.1M 0.01% 739

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS AM's HOLX Position: Q2 2026 in Review

UBS AM sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,299,022 shares — an estimated $174M sold.

UBS AM first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $174M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • UBS AM reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • UBS AM sold 2,299,022 Hologic shares in Q2 2026, an estimated $174M.
  • UBS AM first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
  • UBS AM's Hologic position peaked at $174M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.